Teva offers to buy Mylan in $40.1B cash-and-stock deal

mardi 21 avril 2015

Teva has offered to buy Mylan in a cash-and-stock deal valued at about $40.1 billion. The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as ...

via Business News http://ift.tt/1Jq5AAp

0 commentaires:

Enregistrer un commentaire